Geron Corp (GERN)
$4.71
0.03 (0.63%)
GERN Stock Quote Delayed 30 Minutes
GERN Stock Earnings: Geron Meets EPS, Beats Revenue for Q2 2024
GERN stock results show that Geron met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
2.40B
PE Ratio
-13.08
EPS
-0.36
Volume (Avg. Vol.)
20.95M
Day's Range
$4.70 - $4.83
52-Week Range
$1.68 - $5.34
Dividend & Yield
N/A (N/A)
GERN Stock Predictions, Articles, and Geron Corp News
Why Is Geron (GERN) Stock Up 18% Today?
Geron stock is up on Friday with heavy trading of GERN shares after the FDA approved the company's blood cancer treatment.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning!
GERN Stock Earnings: Geron Beats EPS, Beats Revenue for Q1 2024
GERN stock results show that Geron beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Why Is Geron (GERN) Stock Up 94% Today?
Geron stock is on the rise Friday with heavy trading of GERN shares after the company's blood disorder drug got new backing.
Why Is Geron (GERN) Stock Up Today?
Geron (GERN) stock is gaining on Tuesday following an upgrade for the biopharmaceutical company's shares from Goldman Sachs.
Why Is Geron (GERN) Stock Soaring 50% Today?
Late-stage clinical biopharma Geron delivered positive results for its blood cancer therapeutic, dramatically lifting GERN stock.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why!
